Cargando…

Evaluation of 2 commercial anti-SARS-CoV-2 antibody assays in an immunocompetent and immunocompromised inpatient population with COVID-19

Introduction: During the COVID-19 pandemic, widespread introduction of SARS-CoV-2 antibody testing was introduced without a full understanding of the assays performance or the antibody kinetics following infection with SARS-CoV-2. Methods: We performed an evaluation of 2 anti-SARS-CoV-2 antibody ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harrington, David, Azim, Tahira, Rosmarin, Caryn, Cutino-Moguel, Teresa, Hopkins, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178064/ https://www.ncbi.nlm.nih.gov/pubmed/34224944 http://dx.doi.org/10.1016/j.diagmicrobio.2021.115449

Ejemplares similares

Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts
por: Da Cunha, Teresa, et al.
Publicado: (2021)

Concurrent Infection with SARS-CoV-2 and Pneumocystis jirovecii in Immunocompromised and Immunocompetent Individuals
por: Gioia, Francesca, et al.
Publicado: (2022)

Assessment of commercial SARS-CoV-2 antibody assays, Jamaica
por: Butterfield, Tiffany R., et al.
Publicado: (2021)

The Humoral Immune Response To SARS-CoV-2 Infection And/or Immunization in Immunocompromised Versus Immunocompetent Individuals
por: Illes, Peter, et al.
Publicado: (2022)

Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
por: Ongrádi, Joseph, et al.
Publicado: (2016)

Respiratory Viral Infections in Immunocompetent and Immunocompromised Persons
por: Couch, MD, Robert B., et al.
Publicado: (1997)

Comprehensive Analysis of Disease Pathology in Immunocompetent and Immunocompromised Hosts following Pulmonary SARS-CoV-2 Infection
por: Ramasamy, Santhamani, et al.
Publicado: (2022)

Universal screening for SARS-CoV-2 in pregnant women at term admitted to an East London maternity unit
por: Abeysuriya, Sanduni, et al.
Publicado: (2020)

Efficacy of three antimicrobial mouthwashes in reducing SARS-CoV-2 viral load in the saliva of hospitalized patients: a randomized controlled pilot study
por: Perussolo, Jeniffer, et al.
Publicado: (2023)

Disparities of SARS-CoV-2 Nucleoprotein-Specific IgG in Healthcare Workers in East London, UK
por: Choudhry, Naheed, et al.
Publicado: (2021)

Pathobiology of Aspergillus Fumigatus Endophthalmitis in Immunocompetent and Immunocompromised Mice
por: Gupta, Neha, et al.
Publicado: (2019)

Respiratory adenovirus infections in immunocompetent and immunocompromised adult patients
por: Cederwall, S., et al.
Publicado: (2020)

Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts
por: Berzero, Giulia, et al.
Publicado: (2021)

Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies
por: Hashem, Anwar M., et al.
Publicado: (2020)

Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects
por: Saker, Kahina, et al.
Publicado: (2022)

Comparison of six commercially available SARS-CoV-2 antibody assays—Choice of assay depends on intended use
por: Nilsson, Anna Christine, et al.
Publicado: (2021)

Su1075: SIMILAR RISK OF INFECTION WITH SARS-COV-2 IN IMMUNOCOMPROMISED AND IMMUNOCOMPETENT PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND HEALTHY CONTROLS
por: Kante, Bhaskar, et al.
Publicado: (2022)

Encephalitozoon cuniculi infection among immunocompromised and immunocompetent humans in Egypt
por: ABU-AKKADA, Somaia Saif, et al.
Publicado: (2015)

Computed Tomography Features of Pulmonary Nocardiosis in Immunocompromised and Immunocompetent Patients
por: Mehrian, Payam, et al.
Publicado: (2015)

Delftia acidovorans: A rare pathogen in immunocompetent and immunocompromised patients
por: Bilgin, Huseyin, et al.
Publicado: (2015)

The clinical and radiological characteristics of pulmonary cryptococcosis in immunocompetent and immunocompromised patients
por: Hu, Yan, et al.
Publicado: (2021)

SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy
por: Truffot, Aurélie, et al.
Publicado: (2021)

Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
por: Tuaillon, E, et al.
Publicado: (2020)

Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma
por: Lei, Zhen-ge, et al.
Publicado: (2016)

Clinical analysis in immunocompetent and immunocompromised patients with pulmonary cryptococcosis in western China
por: Qu, Junyan, et al.
Publicado: (2020)

Sphenoid Sinus Aspergilloma in an Immunocompetent and an Immunocompromised Patient: A Case Report
por: Singh, Manraj, et al.
Publicado: (2023)

Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay
por: Murray, Matthew J., et al.
Publicado: (2021)

SARS-CoV-2 in immunocompromised individuals
por: DeWolf, Susan, et al.
Publicado: (2022)

Pulmonary Cryptococcosis: comparison of Cryptococcal antigen detection and radiography in Immunocompetent and Immunocompromised patients
por: Min, Jingqi, et al.
Publicado: (2020)

Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study
por: Dimopoulos, G., et al.
Publicado: (2007)

Viruses and atypical bacteria in the respiratory tract of immunocompromised and immunocompetent patients with airway infection
por: Reckziegel, Maria, et al.
Publicado: (2020)

Comparison of CT findings and histopathological characteristics of pulmonary cryptococcosis in immunocompetent and immunocompromised patients
por: Wang, Dong-xu, et al.
Publicado: (2022)

Diagnostic accuracy of metagenomic next-generation sequencing for cryptococcosis in immunocompetent and immunocompromised patients
por: Su, Yi, et al.
Publicado: (2022)

Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies
por: Mwakingwe-Omari, Agnes, et al.
Publicado: (2023)

Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples
por: Hanssen, Daniëlle A. T., et al.
Publicado: (2021)

Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance
por: Nicholson, Suellen, et al.
Publicado: (2021)

Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays
por: Bal, Antonin, et al.
Publicado: (2021)

SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays
por: Allen, Niamh, et al.
Publicado: (2021)

The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 Infection
por: Syre, Heidi, et al.
Publicado: (2022)

SARS-CoV-2 vaccination in the immunocompromised host
por: Connolly, Caoilfhionn M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t3ils22pfiao4lbavs6sp3o5i4